ID: ALA87742

Max Phase: Preclinical

Molecular Formula: C11H15N3O2S

Molecular Weight: 253.33

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCOC(=O)CC/N=C(\S)Nc1ccccn1

Standard InChI:  InChI=1S/C11H15N3O2S/c1-2-16-10(15)6-8-13-11(17)14-9-5-3-4-7-12-9/h3-5,7H,2,6,8H2,1H3,(H2,12,13,14,17)

Standard InChI Key:  VEQFLHAIDMDMFL-UHFFFAOYSA-N

Associated Targets(non-human)

Glucose-6-phosphatase 38 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 253.33Molecular Weight (Monoisotopic): 253.0885AlogP: 1.73#Rotatable Bonds: 5
Polar Surface Area: 63.58Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 6.78CX Basic pKa: 4.51CX LogP: 2.03CX LogD: 1.43
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.36Np Likeness Score: -1.13

References

1. Farhanullah, Sil D, Tripathi BK, Srivastava AK, Ram VJ..  (2004)  Synthesis and glucose-6-phosphatase inhibitory activity of (thiouriedo)alkanoic acid esters.,  14  (10): [PMID:15109654] [10.1016/j.bmcl.2004.02.079]

Source